A Randomized Controlled Trial Comparing Vonoprazan and Proton Pump Inhibitors for Symptom Relief and Mucosal Healing in Scleroderma-Associated GERD. JOC [Internet]. 2025 Oct. 7 [cited 2025 Dec. 6];24(8s):542-6. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1301